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Abstract
Background Regular exercise has been proposed as a poten-
tial smoking cessation aid.
Purpose This study aimed to determine the effects of an
exercise counseling program on cigarette smoking abstinence
at 24 weeks.
Methods A parallel, two-arm, randomized controlled trial
was conducted. Adult cigarette smokers (n=906) who were
insufficiently active and interested in quitting were random-
ized to receive the Fit2Quit intervention (10 exercise tele-
phone counseling sessions over 6 months) plus usual care
(behavioral counseling and nicotine replacement therapy) or
usual care alone.
Results There were no significant group differences in 7-day
point-prevalence and continuous abstinence at 6 months. The
more intervention calls successfully delivered, the lower the
probability of smoking (OR, 0.88; 95 % CI 0.81–0.97, p=0.01)
in the intervention group. A significant difference was observed
for leisure time physical activity (difference=219.11 MET-
minutes/week; 95 % CI 52.65–385.58; p=0.01).
Conclusions Telephone-delivered exercise counseling may
not be sufficient to improve smoking abstinence rates over
and above existing smoking cessation services. (Australasian
Clinical Trials Registry Number: ACTRN12609000637246.)
Keywords Exercise . Addiction . Smoking cessation .
Behavior change . Randomized controlled trial
Introduction
The adverse health effects of tobacco smoking are well de-
scribed including a wide range of cancers, cardiovascular
disease, chronic obstructive pulmonary disease, other chronic
diseases, and pregnancy complications [1]. Tobacco smoking
is the world’s leading preventable cause of death [2], with
nearly six million deaths each year attributable to tobacco use.
Despite the availability in many countries of effective treat-
ments for smoking dependence (such as behavioral support
and pharmacotherapies), the proportion of people who suc-
cessfully quit smoking and remain abstinent is disappointingly
low [3–5]. New approaches to support the implementation of
existing evidence-based smoking cessation treatments are
needed. One proposed additional aid is exercise [6].
Smoking cessation is associated with withdrawal symp-
toms such as sleep disturbance, irritability, and craving and
weight gain [7]. Many of these negative effects, including
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symptoms of anxiety and psychosocial stress, have been
shown to be ameliorated by exercise [8]. Two recently pub-
lished meta-analyses suggest that acute bouts of moderate
exercise significantly reduce the magnitude of urges to smoke
compared with control conditions [9, 10]. As a consequence,
there has been increased attention in recent years regarding the
role of exercise as a smoking cessation intervention [6].
A Cochrane review [6] of exercise interventions for
smoking cessation identified 15 randomized controlled trials
(n=4298) with adequate follow-up (i.e., at least 6 months after
the quit date). All but one of these studies examined the effect
of exercise in combination with standard smoking cessation
treatment and compared outcomes with a control group who
also received smoking cessation treatment. Only 3 [11–13] of
the 15 trials showed significantly higher abstinence rates in a
physically active group compared with a control group at the
end of treatment, and only one showed a significant benefit of
exercise at follow-up [12].
Methodological issues associated with these trials have
limited the ability to reliably measure the effect of exercise
on smoking cessation rates: Seven trials in the Cochrane
review had fewer than 25 participants in each treatment arm,
and lacked statistical power to detect an effect; six trials
recruited only women, and one recruited only men, limiting
the generalizability of the findings; the exercise interventions
may not have been sufficiently intense or of sufficient duration
to have had an effect on smoking outcomes; finally, the
majority of studies to date can be classified as efficacy trials
and have not been conducted in “real world” settings to
augment existing effective treatments. We sought to address
these methodological concerns and to determine whether in-
tegrating two existing national programs, Quitline and Green
Prescription, both proven effective for smoking cessation [14,
15] and physical activity promotion [16], respectively, could
enhance abstinence rates compared to Quitline support alone.
Methods/Design
Full details of the design and conduct of the Fit2Quit trial have
been published elsewhere [17]. In brief, a parallel two-arm
randomized controlled trial was conducted in New Zealand
between 2009 and 2012. Eligible participants were random-
ized at 1:1 ratio to either receive an exercise intervention plus
usual stop smoking support, or usual stop smoking support
alone (i.e., usual care). The randomization sequence was
generated by the study biostatistician and was stratified by
study center (Auckland and Waikato), sex, and ethnicity
(Māori [indigenous] and non-Māori). Participants were en-
rolled by trained study research assistants and assigned to
interventions. Concealment of allocation was ensured by
means of a central computerized service up to the point of
randomization. The study was registered with the Australasian
Clinical Trials Registry (ACTRN12609000637246).
Participants and Recruitment
Study procedures and terms were approved by the New
Zealand Multi-region Ethics Committee (MEC/09/08/090).
Participants were recruited from the Auckland and Waikato
regions (joint population of 2.0 million) when they called
Quitline, a national smoking cessation telephone support pro-
gram. Participants were eligible if they were daily smokers, at
least 18 years of age, self-reported being interested in quitting
and indicated that intention by having already phoned
Quitline, wanted to be physically active, smoked their first
cigarette within 30 min of waking, and could provide in-
formed consent. Participants were excluded if they had had a
stroke or heart related condition in the previous 2 weeks, were
enrolled in a competing smoking cessation program, had a
medical condition that limited their ability to exercise safely,
were already participating in an exercise program, or were
already meeting the recommended 150 min of physical activ-
ity per week. Recruitment began in January 2010 and ended in
August 2011.
Procedure and Setting
During the registration phone call, eligible participants were
offered either a telephone or face-to-face assessment: Both
assessments collected identical information. Research assis-
tants conducted all assessments according to standard proce-
dures. Participants completed questionnaires on smoking his-
tory, current smoking status, and physical activity at the base-
line assessment. Participants were randomized at the end of
the assessment to either intervention or control groups. Repeat
assessments were conducted at 8 and 24 weeks after the
nominated quit date. Study researchers conducting these as-
sessments were not blinded to treatment allocation. The final
24-week assessment was completed in February 2012.
Measures
Demographics and smoking history, including the Fagerström
Test of Nicotine Dependence [18], were collected at baseline.
Tobacco withdrawal symptoms were assessed with the Mood
and Physical Symptoms Scale [19]. Physical activity levels
were assessed using the International Physical Activity Ques-
tionnaire long form (IPAQ, 20). The International Physical
Activity Questionnaire was developed to obtain international
and comparable estimates of physical activity and the long
version was used in this study because it is suitable for
research or evaluation purposes. The sensitivity of self-
reported instruments to change is difficult to assess and the
metrics for this are often poorly described, but the
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International Physical Activity Questionnaire is an appropriate
measure and provides important contextual information on
activity domains, including at work (physical activity under-
taken as part of one’s job), at home (physical activity under-
taken during domestic duties or gardening), in active transport
(physical activity undertaken while commuting), and during
leisure time (physical activity undertaken solely for exercise,
sport, or recreation). In accordance with International Physical
Activity Questionnaire guidelines [20], results are reported in
metabolic equivalent (MET)-minutes/week.
Usual Care Smoking Cessation
All enrolled participants received usual smoking cessation
services delivered by smoking cessation advisors at Quitline
[15], who provide information and support to quit smoking.
Participants were encouraged to set a quit date and offered
one-to-one telephone support for 3 months, as well as an
exchange card (Quitcard) for up to 8 weeks of subsidized
nicotine replacement therapy (patches, gum, or lozenge) to
be redeemed at a local community pharmacy. The control
group was assigned to usual care alone.
Intervention
Participants randomized to the intervention group received a
comprehensive 6-month home and community-based exercise
program delivered by Green Prescription [21] services in
addition to usual Quitline smoking cessation support. The
Green Prescription exercise intervention was chosen as it has
been shown to be effective at increasing physical activity
among inactive adults [16]. Green Prescription involves a
referral from primary care to agencies that support physical
activity [16]. In this trial, however, registered participants
randomized to the intervention group were referred by the
researcher, without involving the General Practitioner. Once
referred, trained exercise facilitators (patient support persons)
contacted participants and offered telephone counseling to
promote and support exercise behavior. The original program
involves monthly contacts for a total of 3 months; however,
given the increased response burden produced by trying to
change two behaviors at once [22], the number of contacts
was increased to maximize its impact. A total of 10 contacts
(face-to-face and telephone support sessions) were delivered
over 6 months, with the goal of having individuals participat-
ing in a minimum of 30 min of moderate–vigorous aerobic-
based exercise on most days of the week, in line with current
recommendations [23].
The intervention was developed from Social Cognitive
Theory [24] and aimed to enhance participant’s efficacious
beliefs to be physically active. Self-efficacy refers to one’s
situational confidence to perform a specific task or behavior
and has been shown to facilitate exercise initiation and
maintenance in adults [25]. Moreover, self-efficacy based
interventions have proven effective at increasing physical
activity behavior and adherence [26, 27]. Patient support
persons were provided with comprehensive training on self-
efficacy and motivation constructs, as well as telephone
counseling with motivation interviewing concepts and tech-
niques [17] by the research team, in accordance with the
International Conference on Harmonization Good Clinical
Practice guidelines. Full details of the intervention are provid-
ed elsewhere [17]; however, Table 1 summarizes the content
of each of the intervention contacts.
All intervention telephone calls, including those with suc-
cessful or unsuccessful contact, were logged to evaluate ad-
herence with the intervention. For logistic reasons (cost,
returning devices), it was not possible to objectively measure
exercise adherence with a movement device (e.g., accelerom-
eters). Intervention phone calls were also monitored through-
out the study to ensure the fidelity of the intervention delivery.
To achieve this, each patient support person conducted a face-
to-face interview and a “phone call 6” (See Table 1) in the
presence of two study researchers, who provided feedback
focusing on any aspects of the intervention that were missed.
This process was repeated every 6 months and when a new
patient support person was employed.
Outcomes
The primary outcome was self-reported point-prevalence (i.e.,
not a single puff of a cigarette in the past 7 days) at 24 weeks
after the nominated quit date. Verification of quit status was
not undertaken due to the use of telephone-based assessments.
Previous reviews of smoking cessation studies have shown
that rates of misreporting of smoking abstinence are generally
<5 % [28]. Limited face-to-face contact time has been identi-
fied as a circumstance under which the added benefits of
biochemical verification of abstinence are outweighed by the
burden (or cost) of obtaining such information [29]. The
secondary outcomes were self-reported continuous abstinence
(i.e., no more than five cigarettes since the quit date) at
24 weeks after the nominated quit date, self-reported 7-day
point-prevalence at 8 weeks, change from baseline in tobacco
withdrawal symptoms, self-rated chances of quitting, and self-
reported physical activity levels measured with the Interna-
tional Physical Activity Questionnaire.
Sample Size
An a priori sample size estimate indicated that 1,400 partici-
pants (700 per arm) were required to provide 90 % power at
5% level of significance to detect an increase in quit rates over
baseline from 15 to 22.5 % at 6 months, assuming a dropout
rate of 20 %. A 7.5 % difference between groups represents a
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Table 1 Summary of the content of each intervention contact
Contact Time Session content Self-efficacy variable
1—face-to-face Week 1 Welcome participant to the programme
Explain the positive effects of regular physical activity on physical and mental heath Outcome expectancy
Obtain exercise history—what activities have you enjoyed participating in the past?
What time of day do you prefer to exercise? What activities do you currently enjoy?
In the past what factors helped you to participate in regular physical activity, and
what factors hindered you?
Mastery experiences
Discuss normal physiological responses to exercise—highlighting what they are likely
to experience
Physiological responses
Explain the benefit of monitoring progress with a pedometer and exercise log. Explain
perceived exertion scale to monitor intensity of exercise
Mastery experiences and
task efficacy
Exercise prescription—prescribe exercise based on exercise history Task efficacy
Social persuasion—suggest the possibility of exercising with friends/family Social persuasion/peer
modeling
Discuss relapse—and the fact that if “slips” occur (i.e., the participant has a cigarette,
or misses an exercise session) they should not give up
2—phone call 1 Week 2 Discuss the barriers to exercise faced in the last week Barrier efficacy
Discuss the physiological responses to exercise experienced in the previous week.
Based on responses, reinforce that these are normal responses to exercise and any
discomfort often improves with time
Physiological responses
Discuss goal setting using the SMART principle—set specific, measurable,
action-oriented, realistic, time-based goals
3—phone call 2 Week 3 Discuss common barriers to exercise—use the IDEA approach—identify barriers,
develop a strategy, evaluate, assess. Prioritize the most common barriers to exercise
and develop a strategy to overcome them
Barrier efficacy
4—phone call 3 Week 4 Discuss the approach of changing the participant’s perspective to exercise, from one
of fitting exercise into their life to fitting their life around exercise
Scheduling efficacy
Work through another barrier using the IDEA approach Barrier efficacy
Identify high risk situations that will challenge the participant’s exercise compliance
coping skills. Encourage the participant to seek out situations that make exercise
convenient and enjoyable, and to avoid people, places, or situations that may affect
their ability to adhere to their exercise program
Coping efficacy
5—phone call 4 Week 6 Draw the participants attention to where they started and how far they have come Mastery experiences
Discuss how physiological responses to exercise have improved over time Physiological responses
6—phone call 5 Week 8 Plan long-term maintenance of exercise behavior by discussing opportunities for
physical activity at local community facilities and organisations
Coping efficacy
7—phone call 6 Week 12 Discuss how to maintain focus on exercise in different environments, such as when
on holiday—attempt to maintain a similar routine, use exercise as a way to explore
surroundings, etc.
Coping efficacy
8—phone call 7 Week 16 Discuss community options for exercise. Suggest exercise options in the community
based on the participant’s exercise interests. Set some goals regarding community
exercise (if appropriate)
9—phone call 8 Week 20 Discuss community options for exercise. Ask the participant what activities they will
continue to do in the community environment. Discuss location, cost, transport,
with the participant. Help facilitate the participant joining an activity program if needed
Barrier and scheduling
efficacy
10—phone call 9 Week 24 Review previous 6 months, reinforcing progress made to date, fitness improvements,
barriers overcome, etc.
Mastery experiences
Ensure participant is aware they need to continue to exercise regularly, maintaining or
exceeding their prescribed level of exercise, scheduling exercise into their day, and
exercising with others and/or participating in exercise options in the community
(if appropriate)
All calls Review progress since last contact. Provide positive feedback and encouragement
regarding progress
Mastery experiences
Discuss pedometer counts and exercise log Mastery experiences
Provide positive affirmations, support, and encouragement regarding the participants progress Social persuasion
Discuss relapse if required. If relapse has occurred, discuss “coping self-talk” with the
participant, such as “I’ll continue to exercise as I did before…I know that once I get
started, I really enjoy exercising,” etc.
Set goals for the time period until the next contact
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50 % improvement on quit rates, which was considered real-
istic, yet clinically significant.
There were difficulties with recruitment early in the trial,
and we calculated that a final sample of 970 participants (485
per group) would provide 90 % power at 5 % level of signif-
icance to detect a minimum difference of 10 % in smoking
cessation rates, adjusting for 20 % loss to follow up.
Statistical Analysis
Statistical analyses were conducted in 2012 using SAS ver-
sion 9.2 (SAS Institute Inc., Cary, NC, USA) and R version
2.14.1 (R Foundations for Statistical Computing). All statisti-
cal tests were two-tailed, and a 5 % significance level was
maintained throughout the analyses. Treatment evaluations
were performed on the principle of intention-to-treat using
all the data collected from randomized participants. Those
participants whose smoking status could not be ascertained
at follow-up were assumed to be smoking, as recommended
for smoking cessation studies [30].
Chi-squared analyses were used to evaluate the main treat-
ment effect on the primary outcome, with estimation of rela-
tive risks (95 % confidence intervals). As a secondary analy-
sis, the effect of the intervention was evaluated using a logistic
regression model adjusting for baseline stratification factors,
age in years, and strength of urge to smoke. Odds ratios (ORs),
95 % confidence intervals, and two-sided p values are pre-
sented for comparison. Statistical tests and regression models
appropriate for continuous and categorical data were used for
secondary outcomes.
Results
Figure 1 shows participant flow. A total of 906 trial partici-
pants were randomized, with 455 and 451 in the intervention
and control groups, respectively. For intervention and control
groups, loss-to-follow-up rates were 7 and 1 %, respectively,
at 8 weeks and increased to 11 and 4 %, respectively, at
24 weeks.
Table 2 shows the baseline characteristics of all random-
ized participants, with no observed differences between inter-
vention and control groups. The mean overall score for the
Fagerström Test of Nicotine Dependence was 5.6, indicating a
moderate level of dependence (data not shown).
While all participants set a quit date, only 75 and 69 % of
control and intervention group participants, respectively, ac-
tually quit (17 and 24 % of these data were missing).
Cessation Outcomes Smoking abstinence rates at 24 weeks
were moderately high but not significantly different between
intervention and control groups. For 7-day point prevalence,
the abstinence rates were 23 % in the intervention group (105
out of 455) and 22 % in the control group (98 out of 451). The
relative risk (RR) for smoking was 0.98 (95 % CI 0.92–1.05;
p=0.63). Continuous abstinence rates were 17 % (78 out of
455) and 18 % (80 out of 451) in intervention and control
groups, respectively; RR for smoking was 1.01 (95 % CI
0.95–1.07; p=0.81). The ORs estimated in adjusted logistic
regression analyses were close to the RRs with no significant
treatment differences between groups. For those baseline fac-
tors adjusted in the regression model, the probability of
smoking was significantly higher in Māori participants (OR
1.63; 95 % CI 1.12–2.38, p=0.01) and those with higher
baseline strength of urge to smoke (OR 1.28; 95 % CI 1.11–
1.47, p=0.0006) in 7-day point prevalence. Similar ORs were
found in continuous abstinence (data not shown).
Sensitivity Analysis No significant differences were found
between groups for 7-day point prevalence or continuous
abstinence using observed data only (i.e., no imputation).
For 7-day point prevalence, the total number of complete
cases was 683 (75 % of those randomized, N=906), with
328 and 355 in the intervention and control groups, respec-
tively. Of these, 105 participants in the intervention group and
98 in the control group self-reported quitting at 24 weeks
(adjusted OR for smoking, 0.86; 95 % CI 0.62–1.21, p=
0.39). For continuous abstinence, the total number of com-
plete cases was 680 (75 %) with 326 and 354 in the interven-
tion and control groups, respectively. Of these, 78 participants
in the intervention group and 80 in the control group reported
quitting at 24 weeks (adjusted OR for smoking 1.01; 95 % CI
0.70–1.45, p=0.97) (data not shown).
Adherence to the Intervention and Cessation Outcomes Of the
455 participants who were randomized to the intervention
group, 236 (52 %) completed at least seven of the 10 inter-
vention calls (median=7, interquartile range=4–9). One hun-
dred twenty-five participants received less than half of the
scheduled intervention calls (≤4 calls). The number of inter-
vention calls delivered significantly reduced the probability of
smoking at 24 weeks (OR, 0.88; 95 % CI 0.81–0.97, p=0.01)
for those in the intervention group.Moreover, when compared
with the control group, a significant treatment effect on
smoking cessation at 24 weeks was found for those who
received seven intervention calls or more (OR, 0.67; 95 %
CI 0.46–0.98, p=0.04).
Smoking Withdrawal and Behavior There were no statistical-
ly significant intervention effects on tobacco withdrawal
symptoms. For total mood and physical symptoms scores
(range, 1–25), the model adjusted means were 9.90 (SE,
0.21) and 9.92 (SE, 0.20) in the intervention and control
groups, respectively (p=0.96). However, there was a small
but statistically significant difference in the number of ciga-
rettes smoked in the previous 7 days (mean difference, −0.92
198 ann. behav. med. (2014) 48:194–204
cigarettes per day; 95 % CI 0.06–0.39; p=0.006) as well as in
the number of cigarettes smoked since participants’ nominat-
ed quit date (mean difference, −1.01 cigarettes per day; 95 %
CI −1.74 to −0.09, p=0.02) in favor of the intervention group.
Self-rated chance of quitting was also significantly lower in
the intervention group compared to those in the control at
8 weeks (mean difference, 0.23; 95 % CI −1.90 to −0.12; p=
0.02), see Table 3.
Nicotine Replacement Therapy Use At baseline, 200 (44 %)
and 205 (45 %) participants were using nicotine replacement
therapy in the control and intervention groups, respectively,
while another 202 and 195, respectively, indicated that they
had “not got around to it” or the nicotine replacement therapy
products had not arrived yet. There was no effect of baseline
nicotine replacement therapy use on 7-day point prevalence
abstinence at 24 weeks (OR, 1.10; 95 % CI 0.67, 1.83, p=
0.70) in the regression model.
Physical Activity Outcomes A positive intervention effect was
found for leisure time physical activity. Overall, an increase of
526 (SE, 69.18) MET minutes per week was observed in the
intervention group and 307 (SE 66.11) observed in the control
group at 24 weeks (difference, 219.11; 95%CI 52.65–385.58,
p=0.01; see Table 4). There were no other significant differ-
ences between groups for the other activity domains.
Adverse Events A total of 15 (3 %) and 14 (3 %) participants
reported serious adverse events in the control and intervention
groups, respectively, but none were deemed related to the
intervention.
Discussion
The major findings of the present study can be summarized as
follows. In line with many previous studies, no differences in
smoking abstinence rates between the exercise intervention
and control conditions were found; however, there was a very
small effect on the number of cigarettes smoked in the previ-
ous week, which favored the intervention group. There was no
intervention effect for tobacco withdrawal symptoms. Taken
together, these findings suggest that telephone delivered exer-
cise counseling may not be sufficient to improve cessation
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rates over and above existing smoking cessation services such
as Quitline. However, treatment adherence was associated
with reduced probability of smoking among the intervention
group so the study findings may have been different if inter-
vention adherence had been higher.
Despite the null effect observed on smoking abstinence,
this study extends the literature in this area because it is the
first to leverage existing national delivery services for both
smoking cessation and physical activity promotion. The
Green Prescription program was chosen because it has been
shown to be effective at increasing levels of physical activity
among inactive adults [16] and was effective at increasing
leisure time physical activity in the present study, the domain
targeted in the intervention, rather than occupational activity.
We focused on domain-specific physical activity (leisure
time), which is consistent with recommendations by
Table 2 Baseline characteristics for all randomized participants
Control (n=451) Intervention (n=455) Total (n=906)
Age (years), mean±SD 37.3±12.2 37.6±12.2 37.5±12.2
Sex
Male, n (%) 207 (45.9) 208 (45.7) 415 (45.8)
Female, n (%) 244 (54.1) 247 (54.3) 491 (54.2)
Prioritised ethnicity
Māori, n (%) 138 (30.6) 142 (31.2) 280 (30.9)
Pacific, n (%) 55 (12.2) 47 (10.3) 102 (11.3)
NZ European, n (%) 214 (47.5) 218 (47.9) 432 (47.7)
Asian, n (%) 11 (2.4) 13 (2.9) 24 (2.7)
Other, n (%) 33 (7.3) 35 (7.7) 68 (7.5)
Number of cigarettes/day, mean±SD 19.83±9.2 19.41±9.5 19.62±9.3
Age of smoking onset, mean±SD 15.47±4.2 15.54±4.2 15.5±4.2
Years smoking continuously, mean±SD 20.48±11.9 20.15±12.1 20.22±12.0
Fagerström Test of Nicotine Dependence score, mean±SD 5.63±1.95 5.52±1.90 5.57±1.93
Previous quit attempts
Yes, n (%) 348 (77.2) 368 (80.9) 716 (79)
No, n (%) 103 (22.8) 87 (19.1) 190 (21)
Number of quit attempts in previous 12 months
One, n (%) 83 (23.9) 93 (25.3) 176 (24.6)
Two, n (%) 28 (8.1) 37 (10.1) 65 (9.1)
Three, n (%) 14 (4.0) 15 (4.1) 29 (4.1)
Four or more, n (%) 18 (5.2) 20 (5.4) 38 (5.3)
None, n (%) 204 (58.6) 202 (54.9) 406 (56.7)
Do not know, n (%) 1 (0.3) 1 (0.3) 2 (0.3)
Confidence to quit
One (very low), n (%) 8 (1.8) 7 (1.5) 15 (1.7)
Two, n (%) 15 (3.3) 12 (2.6) 27 (3.0)
Three, n (%) 97 (21.5) 83 (18.2) 180 (19.9)
Four, n (%) 140 (31.0) 148 (32.5) 288 (31.8)
Five (very high), n (%) 190 (42.1) 204 (44.8) 394 (43.5)
Missing, n (%) 1 (0.2) 1 (0.2) 2 (0.2)
Physical activity (MET minutes/week), mean±SD
Leisure time domain 601±1,150 557±1,094 579±1,122
Work domain 3,557±6,370 3,998±6,800 3,777±6,589
Active transport domain 437±1,047 430±1403 433±1,238
Domestic and garden domain 1,838±2,877 1,792±2,640 1,815±2,759
Total walking 1,769±2,838 1,744±2,624 1,756±2,731
Total moderate physical activity 3,191±3,728 3,316±3,976 3,254±3,853
Total vigorous physical activity 1,472±3,728 1,733±4,155 1,602±3,947
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developers of the International Physical Activity Question-
naire [31]. There were no statistically significant effects of the
intervention on the other nontargeted domains; however, de-
scriptive data suggest greater increases for the intervention in
the work domain, active transport, and vigorous exercise, but
not for domestic activities or moderate intensity. Collectively,
these data suggest a reallocation of time spent on physical
activities.
Measurement issues also warrant discussion. While the
International Physical Activity Questionnaire—Long Form
is appropriate for research purposes, provides domain specific
information, and permits international comparison, its respon-
siveness to change is less clear [31]. In addition, there are
concerns regarding the interpretation of the high prevalence
estimates obtained from this measure [31]. Future research
should incorporate more objective measures of physical ac-
tivity and intensity, such as accelerometry.
The effects of the intervention on physical activity should
be interpreted with caution because both groups increased
their self-reported physical activity levels from baseline,
suggesting a measurement effect. The finding that the
intervention group spent more time being active in their
leisure time is of interest. Of the handful of previous smoking
cessation trials that have measured or reported physical activ-
ity levels of the control group, findings have been mixed.
Three studies [32–34] found a statistically significant effect
on exercise levels in favor of the intervention group at the end
of treatment, while three others found no differences [35–37].
Of the studies that reported an effect at the end of treatment,
only one found that this effect was maintained at 1-year of
follow-up [32]. As in our study, three trials reported increased
levels of exercise in the control group from end of treatment to
follow-up [33, 34, 38], which may have attenuated any effect
of the intervention. Self-reported walking also increased to a
much greater extent in the intervention group than the control
group, which again was a target of the intervention.
Adherence to the intervention was important. Sensitivity
analyses showed that participants who received at least 70 %
or more of the allocated intervention contacts were less likely
to smoke at the end of the intervention and were 33 % more
likely to have quit compared to those in the control condition.
Given there was no attention-control condition, it is unclear
Table 3 Tobacco withdrawal symptoms and smoking behavior outcomes
Study outcomes Intervention Control Estimated effect size (intervention–control)
Estimate (SE) Estimate
(SE)
Difference
in means
SE 95 % lower
CI
95 % upper
CI
P value
Total MPSSa score (1–25)b 9.90 (0.21) 9.92 (0.20) −0.01 0.25 −0.51 0.49 0.9601
Total MPSSa score (self-reported abstainers only)b 8.57 (0.31) 8.23 (0.32) 0.35 0.39 −0.41 1.11 0.3691
Number of cigarettes smoked per day in the past 7 daysb 4.75 (0.34) 5.67 (0.34) −0.92 0.42 −1.74 −0.09 0.0296
Number of cigarettes smoked per day since nominated quit dateb 5.07 (0.37) 6.08 (0.36) −1.01 0.45 −1.90 −0.12 0.0255
Self-rated chance of quitting at 8 weeksc 3.96 (0.07) 3.73 (0.07) 0.23 0.08 0.06 0.39 0.0067
aMood and physical symptoms scale
b Repeated measures mixed model adjusted for: baseline outcome (as appropriate), age, sex, Māori, center, baseline strength of urge to smoke, and time
cANCOVA Model adjusted for: baseline outcome, age, sex, Māori, center, and baseline strength of urge to smoke
Table 4 Change in physical activity outcomes estimated (repeated measures mixed model adjusted for baseline outcome, stratification factors, age, and
strength of urge to smoke) at 24 weeks
International physical activity questionnaire
domain (MET minutes/week)
Intervention Control Estimated effect size (Intervention–control)
Estimate (SE) Estimate (SE) Difference in
means (SE)
95 % lower CI 95 % higher CI P-value
Leisure-time physical activity 526 (69.2) 307 (66.1) 219.1 (84.8) 52.7 385.6 0.01
Work domain 580.9 (313.8) 538.1 (301.2) 42.8 (384.9) −712.8 798.4 0.91
Active transport domain 164.6 (52.9) 101.9 (50.7) 62.7 (65.0) −64.9 190.3 0.34
Domestic and garden domain 119.6 (124.8) 259.2 (119.7) −139.6 (153.6) −441.1 162.0 0.36
Total walking 364.5 (153.2) 207.9 (126.5) 156.6 (160.8) −159.2 472.3 0.33
Total moderate physical activity 330.8 (173.0) 410.1 (165.1) −79.3 (211.6) −494.8 336.2 0.71
Total vigorous physical activity 871.4 (225.2) 725.0 (215.6) 146.4 (277.2) −397.8 690.6 0.60
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whether this effect is a result of the intervention content or the
greater contact time received. This is an important finding and
suggests that exercise counseling interventions may have an
effect on smoking abstinence for those who choose to use
them. In the present study, we did not assess participant’s
readiness to initiate exercise; however, identifying smokers
who want to quit and screening for readiness to exercise may
enhance adherence to an exercise intervention and thus max-
imize smoking cessation outcomes.
Strengths of this trial include its large sample size (it is the
largest of its kind, excluding one Internet-based trial [36]); the
public health approach and pragmatic nature of the trial, which
incorporated existing and effective behavior change pro-
grams; the peer-reviewed design process; the use of reliable
and valid measures; and the ethnically diverse sample, which
differs from previous trials that have included predominantly
white populations. Notwithstanding these strengths, and at-
tempts to address methodological limitations associated with
previous research, the present study findings are consistent
with other randomized controlled trials conducted in this area
[6]. The few trials that have been conducted, involving phys-
ical activity counseling, have yet to demonstrate an effective
approach to increasing physical activity in a way that may
impact on smoking cessation.
One of the proposed mechanisms for exercise helping
people quit is mitigation of the negative effects of tobacco
withdrawal symptoms. In the present trial, there was no inter-
vention effect on tobacco withdrawal symptoms as measured
with mood and physical symptoms scale, which in turn may
contribute to the null effect of the intervention on quit rates.
However, there was a small, but statistically significant differ-
ence in number of cigarettes smoked per day between groups,
in favor of the intervention group. This latter finding may be
important from a harm reduction perspective, which has been
shown to be at least as effective as abrupt quitting on long term
(>6 months) quit rates [39]. Nevertheless, the clinical rele-
vance of a difference of one cigarette smoked per day between
groups is questionable.
Limitations of this trial include the slow recruitment rate
and the subsequent reduction in sample size. The slow recruit-
ment rate was identified early in the study, and various mea-
sures were implemented (including telephone assessments,
employing additional staff for recruitment, and reducing par-
ticipant burden by decreasing the number of measures) to
improve this. While the final sample was below the initial
target, based on the present findings, it is unlikely that a larger
sample would have altered the conclusion. Second, there was
relatively high and differential loss to follow-up, which is not
uncommon in smoking cessation trials [32, 35, 40], but has
implications when interpreting the findings. Using an
intention-to-treat approach, participants who did not provide
follow-up data were treated as smokers; thus, higher loss to
follow-up potentially attenuated any intervention effect.
However, the sensitivity analysis using observed data also
showed no intervention effect, suggesting the results are ro-
bust. Third, smoking cessation outcomes were self-reported,
and as assessments were conducted predominantly via tele-
phone, it was difficult to objectively verify abstinence. Verifi-
cation of smoking status has been used to prevent over-
reporting of successful quit rates, and has particular relevance
when differences in quit rates exist between groups. However,
recent research has argued that biochemical verification of
abstinence is outweighed by the burden (or cost) of obtaining
such information [29]. It is important to note that cotinine
verification was attempted, but the return rate was minimal.
Fourth, it was not feasible to blind participants to their allo-
cated study arm. Fifth, 30% of intervention group participants
received less than half of the intervention calls, which given
the effect of treatment adherence on smoking quit rates, sig-
nificantly affected the success of the intervention. Lack of
adherence to exercise is not uncommon among previous stud-
ies of exercise interventions for smoking cessation [32, 35, 36,
38, 41]. Finally, exercise was assessed by self-report, which is
associated with recall bias.
Future Research
A key focus for future research is to test different forms of
exercise prescription and to enhance adherence to exercise
interventions. Previous research in the acute setting has shown
that higher intensity exercise was associated with greater
reductions in tobacco withdrawal symptoms and cravings
even when quitters were using nicotine replacement therapy
[42]. Thus, future studies might consider prescribing more
brief bouts of exercise as a strategy for craving and withdrawal
symptom relief, particularly in the first 2–3 weeks of smoking
cessation. With respect to the observed adherence effect,
targeting an exercise intervention for those who are motivated
to exercise or have greater readiness to change may have
greater impact. If exercise works for some individuals and
not others, perhaps interventions for smoking cessation should
include exercise as one intervention component for those
individuals who are motivated to do so.
Finally, where possible, physical activity should be mea-
sured objectively to avoid bias associated with self-report, and
tobacco withdrawal symptoms should be assessed more prox-
imal to the quit data (i.e., within the first week of smoking
abstinence).
Implications
If the intervention had been shown to be effective we had
planned to encourage the integration of two national services
to increase national quit rates. Nevertheless, despite the lack of
an effect of exercise on smoking cessation outcomes, physical
activity is beneficial for a wide range of other health risks and
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outcomes such as depression, cardiovascular disease and type
2 diabetes. Therefore, it is important that physically inactive or
insufficiently active people who smoke are referred to pro-
grams to increase activity levels. Moreover, people engaged in
physical activity promotion programs such as Green Prescrip-
tion who smoke should be actively referred to smoking ces-
sation programs that provide evidence-based interventions,
including pharmacotherapy and behavioral counseling from
a health care professional. It is possible that increasing phys-
ical activity levels in those who smoke may not enhance quit
rates but lead to a reduction in cigarette consumption, which
may lead ultimately to cessation [43]. In the present study, we
found that our intervention was associated with a reduction of
only one cigarette per day; however as highlighted above,
different exercise prescription may have a greater effect on
cigarette consumption than observed here. While the Fit2Quit
intervention content has potential, more focus is needed on
increasing the uptake of the intervention.
Conclusions
A telephone-based exercise counseling intervention in addi-
tion to usual care did not augment abstinence rates at 24 weeks
in adult smokers trying to quit. However, those who received
at least 70 % or more of the allocated intervention contacts
were less likely to smoke at the end of 24 weeks. The exercise
counseling intervention had a positive effect on leisure time
activity and a negligible effect on cigarette consumption.
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